Stock·NYSE·Financial Services
Charles Schwab Corp-The (SCHW)
- Market cap
- $159.03B
- P/E
- 17.47
- Dividend yield
- 1.34%
- Street target
- $124.00median of 23 analysts
- 52-week range
- $83.96 $114.53
The short version
Where SCHW stands today, in four lines, and what CleaRank Financial AI makes of it.
SCHW at a glance
Charles Schwab Corp-The (SCHW): Hold, 53/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($104.44 and $98.15).
- Earnings SCHW beat estimates in 6 of its last 7 quarters, yet fell the next day after 3 of those beats.
- Insiders Insiders sold $440.5M and bought $1.8M over the last 18 months.
- Valuation P/E of 17.5 against 16.5 for the Financial Services sector: broadly in line with peers (+6%).
Figures as of October 17, 2026.
CleaRank Financial AI
Charles Schwab Corp-The (SCHW) carries a CleaRank rating of Hold and a model score of 53/100.
Analysts' views are the strongest support: 18 of 23 rate it a buy, and the median target is 34.9% above the price. Trend is the biggest headwind, since the price is 6.32% below its 200-day average and 11.96% below its 50-day average. Those averages sit at $104.44 for the 50-day and $98.15 for the 200-day. Across the past year, the price has fallen 1.56%.
Only on CleaRank
Figures we compute ourselves from SCHW's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
1/4Price above its 50-day average ›
The price of $91.95 is 12.0% below the 50-day simple moving average of $104.44.Price above its 200-day average ›
The price is 6.3% below the 200-day simple moving average of $98.15.50-day average above the 200-day ›
The 50-day average ($104.44) is 6.4% above the 200-day average ($98.15), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 26% of its 52-week range, between $83.96 and $114.53.
SCHW share price
Pick a period: each tab shows how far SCHW has moved over it, to the last close.
Today's trading
Where SCHW sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
3/5P/E below the sector median ›
The trailing P/E of 17.47 is 5.9% above the Financial Services median of 16.5.P/S below the sector median ›
The price-to-sales ratio of 6.43 is 69.3% above the sector median of 3.8.Profitable over the last 12 months ›
Net income over the last 12 months was $9.7B on revenue of $26.0B, a net margin of 37.4%.Beat estimates in most recent reports ›
SCHW beat the EPS estimate in 6 of its last 7 reports.Pays a dividend ›
The trailing dividend yield is 1.34%, or $1.23 a share a year.
Key statistics
The headline figures for SCHW.
As of October 17, 2026, SCHW trades at $91.95, with a market value of $159.03B, a P/E ratio of 17.47 and a dividend yield of 1.34%.
What the numbers say
CleaRank Financial AI's reading of SCHW's valuation, growth and risks.
SCHW carries a trailing P/E of 17.47, which is 5.9% above the Financial Services median of 16.5. The peer comparison on this page calls that broadly in line with peers. On sales, the P/S of 6.43 sits 69.2% above the sector median of 3.8. The company's market value is $159.0B, and its trailing earnings come to $5.54 per share.
Revenue grew 20.90% over the latest year, which is 9.2 percentage points ahead of the 11.7% median for Financial Services. SCHW turns sales into profit at a net margin of 38.79% and an operating margin of 52.28%, alongside a return on equity of 20.27%, above the sector median of 13.8%. It also reports debt-to-equity of 1.51 and a trailing dividend yield of 1.34% ($1.23 a share a year).
SCHW reported $1.62 per share in its most recent earnings report, dated July 21, 2026, against an estimate of $1.55. That put the result 4.52% above the estimate. In the next session the shares moved up 0.84%.
SCHW beat the EPS estimate in 6 of its last 7 reports, but beats have not guaranteed gains: the stock fell the next day after 3 of them. Looking ahead, analysts expect EPS of $6.47 this fiscal year (growth of 32.9%) and $7.92 the year after (growth of 22.4%).
SCHW's price typically moves about 1.57% in a day, based on the 30-day standard deviation of its daily returns. Its downtrend adds risk for as long as the price remains below both moving averages. Measured from the 52-week high of $114.53, the price is 19.72% lower.
SCHW against the Financial Services sector
How SCHW compares with the median Financial Services stock CleaRank tracks.
Price to earnings vs sector: Valuation is broadly in line with sector peers (6% difference), suggesting fair market pricing relative to industry standards.
Return vs XLF: Since May 6, 2025, SCHW has gained 11.0% against a gain of 12.5% for XLF.
Performance against XLF
SCHW and the Financial Services sector fund over the same days.
Revenue and earnings
How much SCHW sells, and how much of it becomes profit.
Revenue growth: Revenue grew 22.0% in FY2025 to $23.9B, from $19.6B a year earlier.
Profit margin: The net margin was 37.0% in FY2025, up from 30.3% the year before.
Profitable: SCHW earned $8.9B in FY2025.
Earnings reality check
Did SCHW beat what analysts expected, and how did the stock react?
Earnings record: SCHW beat the analyst estimate in 6 of the last 7 quarters.
Market reaction: The stock fell in the first session after 3 of those 6 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Jul 21, 2026after close | $1.55 | $1.62 | +4.52% | +0.84% | +6.01% |
| Apr 16, 2026after close | $1.40 | $1.43 | +2.14% | -0.37% | -3.99% |
| Jan 21, 2026after close | $1.39 | $1.39 | +0.00% | +2.22% | +1.65% |
| Oct 16, 2025after close | $1.25 | $1.31 | +4.80% | +0.78% | +1.27% |
| Jul 18, 2025after close | $1.10 | $1.14 | +3.64% | +0.47% | +1.32% |
| Apr 17, 2025after close | $1.01 | $1.04 | +2.97% | -1.58% | +4.98% |
| Jan 20, 2025after close | $0.92 | $1.01 | +9.78% | -0.41% | +0.95% |
As of October 17, 2026, SCHW has beaten the analyst EPS estimate in 6 of its last 7 reported quarters and fell in the first trading session after 3 of those beats; its latest report, on July 21, 2026, came in 4.52% above the estimate and the stock moved +0.84% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
0/3RSI not overbought or oversold ›
The 14-day RSI is 27.8, in oversold territory.RSI above 50 ›
An RSI of 27.8 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of SCHW
The score, the reasoning behind it, and what could move the price next.
Charles Schwab Corp-The (SCHW) sits beneath both of its main moving averages, with the price at $91.95. It is 11.96% below the 50-day average of $104.44 and 6.32% below the 200-day average of $98.15. The stock stands at 26% of its 52-week range, which leaves it 9.52% above the 52-week low of $83.96.
On momentum, the 14-day RSI reads 27.8, in oversold territory, with the MACD line negative. Every period on the chart shows a loss, with the price down 9.46% over the past three months, 0.36% over the past six months and 1.56% over the past year. The price fell 2.35% in the last session on volume 59.8% above its average.
Earnings beat ›
The July 21, 2026 report beat the EPS estimate by 4.52%, and the share price rose 0.84% in the first session after it.
Source: Earnings report, July 21, 2026Rating reaffirmed ›
Morgan Stanley kept its Overweight rating on October 9, 2026.
Source: Analyst action, Morgan Stanley, October 9, 2026
New analyst coverage ›
Wells Fargo started coverage at Equal-Weight on October 2, 2026.
Source: Analyst action, Wells Fargo, October 2, 2026
- Keep an eye on the two closest levels: the 20-day EMA at $98.00, which sits above the price, and the 52-week low at $83.96, which sits below it.
- The 14-day RSI is 27.8, which is oversold, and the MACD line is negative. Readings above 70 or below 30 point to stretched momentum.
- In the first session after the July 21, 2026 report, the share price climbed 0.84%. Over the last 7 reports, SCHW has beaten estimates in 6 of them.
SCHW remains in a downtrend while it trades under both its 50-day average of $104.44 and its 200-day average of $98.15. A close back above the 200-day average would be the first sign of a repair. Overhead, the 20-day EMA at $98.00 is the first level a recovery would have to clear.
Below the current price, the next level to watch is the 52-week low of $83.96.
Technical indicators
Momentum and trend for SCHW, from its daily closes.
As of October 17, 2026, with SCHW at $91.95, its 14-day RSI is 27.8 (oversold territory), its 50-day simple moving average is $104.44 and its 200-day is $98.15.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What SCHW moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, SCHW's 1-year correlation of daily returns is +0.44 with S&P 500 (SPY), +0.32 with Nasdaq 100 (QQQ), +0.21 with Bitcoin (BTC) and +0.04 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
18 of 23 analysts rate it a buy or strong buy, 4 a hold and 1 a sell.Median target above the price ›
The median 12-month target of $124.00 is 34.9% above the price.More buy ratings than three months ago ›
18 of 23 rate it a buy now, against 17 of 21 three months ago.
SCHW Wall Street View
12-month price targets
The price, $91.95, sits below every analyst's target.
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 9, 2026 | Morgan Stanley | Maintains | Overweight |
| Oct 7, 2026 | UBS | Maintains | Buy |
| Oct 7, 2026 | Barclays | Maintains | Overweight |
| Oct 5, 2026 | B of A Securities | Maintains | Underperform |
| Oct 2, 2026 | Piper Sandler | Maintains | Neutral |
| Oct 2, 2026 | Wells Fargo | Initiates | Equal-Weight |
As of October 17, 2026, 23 Wall Street analysts cover SCHW: 18 rate it a buy or strong buy, 4 a hold and 1 a sell or strong sell. Their 12-month price targets range from $95.00 to $150.00, with a median of $124.00, 34.9% above the price of $91.95.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
SCHW trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from SCHW's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much SCHW tends to move, against the market and on its own.
The long record
SCHW's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
3/4Average daily move under 2% ›
The price has moved 1.57% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 51.0%, from May 2018 to March 2020, regained by January 2021.Most 1-year holds ended higher ›
61% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $32,958, against $42,058 in the S&P 500 (SPY).
SCHW Drawdowns & Recovery
As of October 17, 2026, SCHW's worst peak-to-trough fall over the last 10 years with dividends reinvested was -51.0% (May 2018 to March 2020); it regained that peak by January 2021, 10 months after the low, and 61% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into SCHW in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: SCHW trailed the S&P 500 over this period: $32,958 against $42,058.
A $10,000 investment in SCHW in October 2016 would be worth about $32,958 today with dividends reinvested, compared with about $42,058 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to SCHW, and which have not.
Strongest month, November: an average of +10.33%, up in 9 of 10 years.
Weakest month, March: an average of -3.99%, up in 5 of 10 years.
This month, October: has averaged +1.73%, up in 5 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, SCHW's strongest calendar month has been November (average +10.33%, up in 9 of 10 years) and its weakest March (average -3.99%, up in 5 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in SCHW, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in SCHW today could grow to about $21,924 by 2036 in the base case, with a 90th-percentile outcome near $84,099 and a 10th-percentile outcome around $5,716. The simulation models price only; at today's 1.34% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
SCHW Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $126 for SCHW by 2030 in the base case, from $91.95 today (1.4x over 4 years). The 10th-percentile path ends near $53.78. These are outcomes of a Monte Carlo simulation run on SCHW's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $65.01 | $99.46 | $152 | |
| 2028 | $58.97 | $108 | $196 | |
| 2029 | $55.72 | $116 | $243 | |
| 2030 | $53.78 | $126 | $295 | |
| 2031 | $52.62 | $136 | $352 |
Method: a lognormal simulation of SCHW's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
SCHW insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: Insiders bought $1.8M on the open market and sold $440.5M.
As of October 17, 2026, SCHW insiders reported 98 open-market sales worth $440.5M and 1 open-market purchase worth $1.8M over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Oct 1, 2026 | Neesha Hathi
Officer
|
Sell | 5.0K | $489.0K |
| Oct 1, 2026 | Neesha Hathi
Officer
|
Option | 5.0K | $209.9K |
| Sep 1, 2026 | Neesha Hathi
Officer
|
Sell | 3.2K | $346.4K |
| Sep 1, 2026 | Neesha Hathi
Officer
|
Option | 3.2K | $165.4K |
| Aug 28, 2026 | Walter W Bettinger II
Chairman of the Board
|
Sell | 74.4K | $8.3M |
| Aug 28, 2026 | Neesha Hathi
Officer
|
Sell | 3.2K | $343.5K |
| Aug 28, 2026 | Walter W Bettinger II
Chairman of the Board
|
Option | 74.4K | $3.5M |
| Aug 27, 2026 | Charles R Schwab Jr.
Chairman of the Board
|
Grant | 9.3K | - |
| Aug 26, 2026 | Carolyn Schwab-Pomerantz
Director
|
Sell | 9.2K | $1.0M |
| Aug 24, 2026 | Walter W Bettinger II
Chairman of the Board
|
Sell | 176.2K | $20.0M |
| Aug 24, 2026 | Charles R Schwab Jr.
Chairman of the Board
|
Sell | 117.0K | $13.2M |
| Aug 24, 2026 | Walter W Bettinger II
Chairman of the Board
|
Option | 176.2K | $8.2M |
| Aug 18, 2026 | Charles R Schwab Jr.
Chairman of the Board
|
Grant | 100.1K | - |
| Aug 17, 2026 | Jonathan S Beatty
Officer
|
Sell | 1.0K | $111.3K |
| Aug 13, 2026 | Dennis Howard
Chief Technology Officer
|
Sell | 2.2K | $241.8K |
| Aug 12, 2026 | Charles R Schwab Jr.
Chairman of the Board
|
Sell | 46.4K | $5.0M |
| Aug 11, 2026 | Charles R Schwab Jr.
Chairman of the Board
|
Sell | 46.4K | $5.0M |
| Aug 10, 2026 | Nigel J. Murtagh
Officer
|
Sell | 26.7K | $2.9M |
| Aug 10, 2026 | Nigel J. Murtagh
Officer
|
Option | 26.7K | $1.2M |
| Aug 7, 2026 | Paula A Sneed
Director
|
Sell | 5.3K | $564.0K |
| Aug 6, 2026 | Charles R Schwab Jr.
Chairman of the Board
|
Grant | 37.2K | - |
| Aug 5, 2026 | Jonathan M Craig
Officer
|
Sell | 21.8K | $2.3M |
| Aug 5, 2026 | Carolyn Schwab-Pomerantz
Director
|
Sell | 18.6K | $2.0M |
| Aug 5, 2026 | Jonathan M Craig
Officer
|
Option | 21.8K | $1.0M |
| Aug 4, 2026 | Charles R Schwab Jr.
Chairman of the Board
|
Sell | 142.9K | $15.1M |
| Aug 4, 2026 | Carolyn Schwab-Pomerantz
Director
|
Sell | 22.6K | $2.4M |
| Jul 29, 2026 | Charles R Schwab Jr.
Chairman of the Board
|
Sell | 143.5K | $15.2M |
| Jul 28, 2026 | Walter W Bettinger II
Chairman of the Board
|
Sell | 285.9K | $29.8M |
| Jul 28, 2026 | Dennis Howard
Chief Technology Officer
|
Sell | 28.0K | $2.9M |
| Jul 28, 2026 | Carolyn Schwab-Pomerantz
Director
|
Sell | 22.7K | $2.4M |
| Jul 28, 2026 | Walter W Bettinger II
Chairman of the Board
|
Option | 285.9K | $14.9M |
| Jul 28, 2026 | Dennis Howard
Chief Technology Officer
|
Option | 28.0K | $1.8M |
| Jul 28, 2026 | Charles R Schwab Jr.
Chairman of the Board
|
Grant | 60.0K | - |
| Jul 28, 2026 | Carolyn Schwab-Pomerantz
Director
|
Grant | 271 | - |
| Jul 27, 2026 | Nigel J. Murtagh
Officer
|
Sell | 32.9K | $3.4M |
| Jul 27, 2026 | Nigel J. Murtagh
Officer
|
Option | 32.9K | $1.5M |
| Jul 24, 2026 | Charles R Schwab Jr.
Chairman of the Board
|
Sell | 45.5K | $4.6M |
| Jul 23, 2026 | Peter J. Morgan III
General Counsel
|
Sell | 7.0K | $709.3K |
| Jul 21, 2026 | Nigel J. Murtagh
Officer
|
Sell | 4.1K | $422.1K |
| Jul 21, 2026 | Jonathan S Beatty
Officer
|
Sell | 2.0K | $208.4K |
| Jul 21, 2026 | Nigel J. Murtagh
Officer
|
Option | 4.1K | $189.7K |
| Jul 7, 2026 | Jonathan M Craig
Officer
|
Sell | 21.8K | $2.2M |
| Jul 7, 2026 | Jonathan S Beatty
Officer
|
Sell | 2.0K | $204.0K |
| Jul 7, 2026 | Jonathan M Craig
Officer
|
Option | 21.8K | $1.0M |
| Jul 6, 2026 | Jonathan S Beatty
Officer
|
Sell | 4.0K | $394.1K |
| Jun 23, 2026 | Stephen A Ellis
Director
|
Option | 2.3K | $56.7K |
| May 28, 2026 | Richard A. Wurster
Chief Executive Officer
|
Buy | 22.0K | $1.8M |
| May 26, 2026 | John K Adams Jr
Director
|
Grant | 1.6K | - |
| May 26, 2026 | Marianne Catherine Brown
Director
|
Grant | 1.6K | - |
| May 26, 2026 | Joan T. Dea
Director
|
Grant | 1.6K | - |
| May 26, 2026 | Christopher V Dodds
Director
|
Grant | 1.6K | - |
| May 26, 2026 | Stephen A Ellis
Director
|
Grant | 1.6K | - |
| May 26, 2026 | Frank C Herringer
Director
|
Grant | 1.6K | - |
| May 26, 2026 | Charles Anthony Ruffel
Director
|
Grant | 1.6K | - |
| May 26, 2026 | Arun Sarin
Director
|
Grant | 1.6K | - |
| May 26, 2026 | Carolyn Schwab-Pomerantz
Director
|
Grant | 1.6K | - |
| May 26, 2026 | Paula A Sneed
Director
|
Grant | 1.6K | - |
| May 22, 2026 | Charles R Schwab Jr.
Chairman of the Board
|
Grant | 210.0K | - |
| May 21, 2026 | Joan T. Dea
Director
|
Grant | 835 | - |
| May 19, 2026 | Charles R Schwab Jr.
Chairman of the Board
|
Sell | 27.5K | $2.5M |
| May 18, 2026 | Charles R Schwab Jr.
Chairman of the Board
|
Sell | 27.5K | $2.5M |
| May 15, 2026 | Charles R Schwab Jr.
Chairman of the Board
|
Grant | 5.3K | - |
| May 13, 2026 | Arun Sarin
Director
|
Sell | 2.5K | $227.9K |
| May 13, 2026 | Arun Sarin
Director
|
Option | 7.9K | $227.8K |
| May 6, 2026 | Charles R Schwab Jr.
Chairman of the Board
|
Sell | 218.6K | $20.1M |
| May 5, 2026 | Carolyn Schwab-Pomerantz
Director
|
Sell | 9.9K | $914.6K |
| May 5, 2026 | Carolyn Schwab-Pomerantz
Director
|
Option | 9.9K | $313.7K |
| May 1, 2026 | Charles R Schwab Jr.
Chairman of the Board
|
Sell | 168.7K | $15.4M |
| Apr 28, 2026 | Frank C Herringer
Director
|
Sell | 2.5K | $228.3K |
| Apr 28, 2026 | Frank C Herringer
Director
|
Option | 7.9K | $227.8K |
| Apr 27, 2026 | Charles R Schwab Jr.
Chairman of the Board
|
Sell | 72.9K | $6.6M |
| Apr 15, 2026 | Paul V Woolway
Officer
|
Sell | 15.9K | $1.6M |
| Apr 15, 2026 | Paul V Woolway
Officer
|
Option | 15.9K | $826.7K |
| Apr 14, 2026 | Nigel J. Murtagh
Officer
|
Sell | 41.3K | $4.1M |
| Apr 14, 2026 | Jonathan M Craig
Officer
|
Sell | 21.8K | $2.2M |
| Apr 14, 2026 | Jonathan M Craig
Officer
|
Option | 21.8K | $1.0M |
| Apr 14, 2026 | Nigel J. Murtagh
Officer
|
Option | 41.3K | $2.1M |
| Mar 24, 2026 | Stephen A Ellis
Director
|
Option | 9.8K | $281.7K |
| Mar 3, 2026 | Paul V Woolway
Officer
|
Sell | 22.0K | $2.1M |
| Mar 3, 2026 | Jonathan M Craig
Officer
|
Sell | 14.5K | $1.4M |
| Mar 3, 2026 | Dennis Howard
Chief Technology Officer
|
Sell | 10.1K | $956.2K |
| Mar 3, 2026 | Nigel J. Murtagh
Officer
|
Sell | 7.2K | $681.5K |
| Mar 2, 2026 | Paul V Woolway
Officer
|
Option | 15.9K | $826.8K |
| Feb 27, 2026 | Jonathan S Beatty
Officer
|
Sell | 2.0K | $193.5K |
| Feb 27, 2026 | Walter W Bettinger II
Chairman of the Board
|
Grant | 141.8K | - |
| Feb 27, 2026 | Jonathan M Craig
Officer
|
Grant | 25.6K | - |
| Feb 27, 2026 | Dennis Howard
Officer
|
Grant | 16.3K | - |
| Feb 27, 2026 | Peter J. Morgan III
General Counsel
|
Grant | 11.3K | - |
| Feb 27, 2026 | Nigel J. Murtagh
Officer
|
Grant | 16.3K | - |
| Feb 27, 2026 | Charles R Schwab Jr.
Chairman of the Board
|
Grant | 38.8K | - |
| Feb 27, 2026 | Paul V Woolway
Officer
|
Grant | 8.2K | - |
| Feb 27, 2026 | Richard A. Wurster
Chief Executive Officer
|
Grant | 62.1K | - |
| Feb 26, 2026 | Stephen A Ellis
Director
|
Sell | 10.7K | $1.0M |
| Feb 25, 2026 | Dennis Howard
Officer
|
Sell | 27.9K | $2.7M |
| Feb 25, 2026 | Dennis Howard
Officer
|
Option | 27.9K | $1.8M |
| Feb 10, 2026 | Charles R Schwab Jr.
Chairman of the Board
|
Sell | 158.6K | $16.9M |
| Feb 9, 2026 | Charles R Schwab Jr.
Chairman of the Board
|
Grant | 60.0K | - |
| Feb 6, 2026 | Christopher V Dodds
Director
|
Sell | 11.8K | $1.2M |
| Feb 6, 2026 | Christopher V Dodds
Director
|
Option | 11.8K | $757.1K |
| Feb 4, 2026 | Walter W Bettinger II
Chairman of the Board
|
Sell | 257.4K | $26.8M |
| Feb 4, 2026 | Charles R Schwab Jr.
Chairman of the Board
|
Sell | 164.6K | $17.1M |
| Feb 4, 2026 | Walter W Bettinger II
Chairman of the Board
|
Option | 257.4K | $11.1M |
| Feb 2, 2026 | Peter J. Morgan III
General Counsel
|
Sell | 7.6K | $792.8K |
| Feb 2, 2026 | Peter J. Morgan III
General Counsel
|
Option | 7.6K | $504.8K |
| Jan 29, 2026 | Charles R Schwab Jr.
Chairman of the Board
|
Sell | 145.7K | $15.0M |
| Jan 22, 2026 | Carolyn Schwab-Pomerantz
Director
|
Sell | 42.9K | $4.5M |
| Jan 22, 2026 | Jonathan S Beatty
Officer
|
Sell | 2.0K | $210.0K |
| Jan 22, 2026 | Jonathan S Beatty
Officer
|
Option | 2.0K | $92.8K |
| Dec 23, 2025 | Jonathan S Beatty
Officer
|
Sell | 2.0K | $204.0K |
| Dec 23, 2025 | Jonathan S Beatty
Officer
|
Option | 2.0K | $92.8K |
| Dec 16, 2025 | Stephen A Ellis
Director
|
Option | 1.9K | $61.5K |
| Nov 19, 2025 | Charles Anthony Ruffel
Director
|
Grant | 8.4K | - |
| Nov 13, 2025 | Paula A Sneed
Director
|
Grant | 8.7K | - |
| Nov 12, 2025 | Jonathan S Beatty
Officer
|
Sell | 3.1K | $301.1K |
| Nov 12, 2025 | Jonathan S Beatty
Officer
|
Option | 3.1K | $142.5K |
| Nov 12, 2025 | Nigel J. Murtagh
Officer
|
Grant | 1.0K | - |
| Nov 12, 2025 | Charles R Schwab Jr.
Chairman of the Board
|
Grant | 52.5K | - |
| Nov 10, 2025 | Walter W Bettinger II
Chairman of the Board
|
Grant | 61.4K | - |
| Nov 10, 2025 | Carolyn Schwab-Pomerantz
Director
|
Grant | 298 | - |
| Nov 10, 2025 | Paul V Woolway
Officer
|
Grant | 1.1K | - |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 17, 2026.